FDA 483 - Intas Pharmaceuticals Ltd. - September 17, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Intas Pharmaceuticals Limited in Dehradun, India, was inspected from September 8-17, 2025, and received a Form 483 with three observations. The inspection revealed significant issues including inadequate review of unexplained discrepancies, unsupported drug product shelf-life, and numerous out-of-specification results. Furthermore, the firm was cited for unauthorized modifications to electronic batch records without proper audit trails, and for incomplete batch production and control records.
ID · 80904191-e341-4855-ab11-f5e543dc08e3